Features & Benefits

ArjoHuntleigh's Skin IQ® Microclimate Manager (MCM) is a fluid resistant, vapor permeable, single patient use mattress cover for use with a pressure redistribution surface to help prevent and treat Stage I-IV pressure ulcers.  Powered by Negative Airflow Technology (NAT), Skin IQ MCM continually draws away excess moisture from the skin/surface interface and helps control skin temperature.

Outstanding Moisture Vapor Transfer Rate (MVTR)

  • Skin IQ MVTR of 130 (g/m2)/hr(1) is greater than the average 97.7 (g/m2)/hr of conventional Low Air Loss (LAL) surfaces(2).

Excellent moisture removal

  • Bench studies show that Skin IQ MCM removes 3.8 times more moisture at the skin/surface interface than the same surface without Skin IQ MCM(3).

Can help to reduce skin maceration

  • By removing excess moisture from the skin/surface interface, Skin IQ MCM could help to reduce the incidence of periwound maceration(4,5).

Reduces temperature at skin/surface interface

  • Bench studies show that Negative Airflow Technology (NAT) reduces the temperature at the skin/surface interface by more than 1°C in 45 minutes(2), which translates to a 10% reduction in the tissue metabolism rate(6).

Reduces shear and friction

  • Bench studies show that Skin IQ MCM's top layer material reduces shear and friction to help prevent and treat pressure ulcers(7).

Helps control odor

  • Bench studies show that Negative Airflow Technology (NAT) significantly reduces odor at the skin/surface interface compared to the same surface without airflow(8).

Helps improve resident/patient comfort

  • Skin IQ MCM helps maintain resident/patient comfort and wellness.
  • In a study of 16 healthy participants using Skin IQ MCM on a pressure redistribution surface, it significantly improved the level of comfort(2).

Provides a bacterial and viral barrier

  • The top layer of Skin IQ MCM is a bacterial and viral barrier(9).

Contains bacteriocidal properties

  • The top and middle layers of Skin IQ MCM contain a bacteriocidal agent(10).
  • Bench studies show that NAT reduces Staphylococcus aureus growth by 2.24 logs during a 24 hour period compared to a hospital bed sheet(11).

No reduction of pressure redistribution efficiency

  • Pressure mapping tests (performed on various ArjoHuntleigh powered and non-powered therapeutic surfaces) show that Skin IQ MCM does not diminish the pressure redistribution properties of the underlying mattress(12).

Can help reduce the risk of entrapment

  • Skin IQ MCM is designed to fit tightly onto a pressure redistribution surface, which eliminates the chance of a gap between the mattress and the bed frame or side rail, which may occur if an undersized overlay is placed on top of a mattress.

Provides early intervention

  • The immediate availability of Skin IQ MCM allows early intervention, which may help reduce the length of stay(13).

 

References

  1. Data on file
  2. Reger SI, Adams TC, Madklebust JA, Sahgal V. Validation test for climate control on air-loss supports. Arch Rhys Med Rehabil. 2001;82(5):597-603.
  3. Data on file.
  4. Data on file.
  5. Bergstrom N, Braden BJ, Laguzza A, Holman V. The Braden Scale for predicting pressure sore risk. Nurs Res. 1987;36(4):205-210.
  6. Flam E and Raab L. What is low air loss therapy? European Pressure Ulcer Advisory Panel. Aberdeen, Scotland. May 5-7, 2005. Available at: http://www.epuap.org/aberdeen/page3.htm
  7. Data on file.
  8. Data on file.
  9. Data on file.
  10. Data on file.
  11. Data on file.
  12. Data on file.
  13. Dorner B, Posthauer M, Thomas D. The Role of Nutrition in Pressure Ulcer Prevention and Treatment. National Pressure Ulcer Advisory Panel White Paper. 2009;1-15.